Last reviewed · How we verify

NCT05529602

Post Isometric Relaxation and Core Stability Exercises in Sacroiliac Joint Dysfunction

Completed NA Last updated 18 September 2023
What this trial tests

NA trial testing conventional physical therapy in Lower Back Pain in 54 participants. Completed in 30 August 2022.

Timeline
1 December 2021
Primary endpoint
30 August 2022
30 August 2022

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment54
Start date1 December 2021
Primary completion30 August 2022
Estimated completion30 August 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 20 to 35, female only, with Lower Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is growing evidence on the effects of post isometric relaxation exercises and core stability exercises on pain and disability secondary to various disorders. However, very few studies have explored their effects in postpartum Sacroiliac joint dysfunction. The aim of this study will be to compare the effects of post isometric relaxation exercises and core stability exercises on pain in postpartum Sacroiliac joint dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of conventional physical therapy

Trials testing the same drug.

Other recruiting trials for Lower Back Pain

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05529602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing